Spatial multi-omics characterizes GPR35-relevant lipid metabolism signatures across liver zonation in MASLD
Life Metabolism · 01.12.2024 · 3 (6)
DOI: 10.1093/lifemeta/loae021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Metabolism, online erschienen am 31.05.2024. Verfasst von Wuxiyar Otkur und 19 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Phytochemistry and Natural Medicines, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, Liaoning 116023, C…. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a metabolic disease that can progress to metabolic dysfunction-associated steatohepatitis (MASH), cirrhosis, and cancer. The zonal distribution of biomolecules in the liver is implicated in mediating the disease progression. Recently, G-protein-coupled receptor 35 (GPR35) has been highlighted to play a role in MASLD, but the precise mechanism is not fully understood, particularly, in a liver-zonal manner. Here, we aimed to identify spatially distributed specific genes and metabolites in different liver zonation that are regulated by GPR35 in MASLD, by combining lipid metabolomics, spatial transcriptomics (ST), and spatial metabolomics (SM). We found that GPR35 influenced lipid accumulation, inflammatory and metabolism-related factors in specific regions, notably affecting the anti-inflammation factor ELF4 (E74 like E-twenty six (ETS) transcription factor 4), lipid homeostasis key factor CIDEA (cell death-inducing DNA fragmentation factor alpha (DFFA)-like effector A), and the injury response-related genes SAA1/2/3 (serum amyloid A1/2/3), thereby impacting MASLD progression. Furthermore, SM elucidated specific metabolite distributions across different liver regions, such as C10H11N4O7P (3ʹ,5ʹ-cyclic inosine monophosphate (3ʹ,5ʹ-IMP)) for the central vein, and this metabolite significantly decreased in the liver zones of GPR35-deficient mice during MASLD progression. Taken together, GPR35 regulates hepatocyte damage repair, controls inflammation, and prevents MASLD progression by influencing phospholipid homeostasis and gene expression in a zonal manner.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Phytochemistry and Natural Medicines, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, Liaoning 116023, China.
- School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shengyang, Liaoning 110016, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
- Department of Biochemistry & Molecular Biology, School of Life Sciences, China Medical University, Shenyang, Liaoning 110122, China.
- Laboratory of High-Resolution Mass Spectrometry Technologies, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, Liaoning 116023, China.
Zitieren
APA
Otkur, W., Zhang, Y., Li, Y., Bao, W., Feng, T., Wu, B., Ma, Y., Shi, J., Wang, L., Pei, S., Wang, W., Wang, J., Zhao, Y., Liu, Y., Li, X., Xia, T., Wang, F., Chen, D., Liang, X., & Piao, H. L. (2024). Spatial multi-omics characterizes GPR35-relevant lipid metabolism signatures across liver zonation in MASLD. Life Metabolism, 3(6). https://doi.org/10.1093/lifemeta/loae021
Vancouver
Otkur W, Zhang Y, Li Y, Bao W, Feng T, Wu B, et al. Spatial multi-omics characterizes GPR35-relevant lipid metabolism signatures across liver zonation in MASLD. Life Metabolism. 2024;3(6). doi:10.1093/lifemeta/loae021
BibTeX
@article{Otkur2024,
author = {Otkur, Wuxiyar and Zhang, Yiran and Li, Yirong and Bao, Wenjun and Feng, Tingze and Wu, Bo and Ma, Yaolu and Shi, Jing and Wang, Li and Pei, Shaojun and Wang, Wen and Wang, Jixia and Zhao, Yaopeng and Liu, Yanfang and Li, Xiuling and Xia, Tian and Wang, Fangjun and Chen, Di and Liang, Xinmiao and Piao, Hai-Long},
title = {Spatial multi-omics characterizes GPR35-relevant lipid metabolism signatures across liver zonation in MASLD},
journal = {Life Metabolism},
year = {2024},
volume = {3},
number = {6},
doi = {10.1093/lifemeta/loae021}
}
EUVIMED